Follow-up guidelines after radical or partial nephrectomy for localized and locally advanced renal cell carcinoma

Journal of the Canadian Urological Association

Volumn 3, Issue 1, 2009, Pages 73-76

  Kassouf, Wassim ^a   Siemens, Robert ^b   Morash, Christopher ^c   Lacombe, Louis ^d   Jewett, Michael ^e   Goldenberg, Larry ^f   Chin, Joseph ^g   Chetner, Michael ^h   Wood, Christopher G ⁱ   Tanguay, Simon ^a   Aprikian, Armen G ^j  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d LAVAL UNIVERSITY   (Canada)

^e PRINCESS MARGARET HOSPITAL   (Canada)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g UNIVERSITY OF WESTERN ONTARIO   (Canada)

^h UNIVERSITY OF ALBERTA   (Canada)

ⁱ UNIVERSITY OF TEXAS   (United States)

^j MCGILL UNIVERSITY   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70350292065     PISSN: 19116470     EISSN: 19116470     Source Type: Journal    
DOI: 10.5489/cuaj.1028     Document Type: Article

References (24)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006; 56:106-30.
2. Bergstrom A, Hsieh CC, Lindblad P, et al. Obesity and renal cell cancer - a quantitative review. Br J Cancer 2001;85:984-90 (Pubitemid 33016001)
3. Lindblad P. Epidemiology of renal cell carcinoma. Scand J Surg 2004;93:88-96.
4. Skolarikos A, Alivizatos G, Laguna P, et al. A review on follow-up strategies for renal cell carcinoma after nephrectomy. [discussion 1501]. Eur Urol 2007;51:1490-500.
5. Lau WK, Blute ML, Weaver AL, et al. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc 2000;75:1236-42.
6. Bani-Hani AH, Leibovich BC, Lohse CM, et al. Associations with contralateral recurrence following nephrectomy for renal cell carcinoma using a cohort of 2,352 patients. J Urol 2005;173:391-394.
7. Itano NB, Blute ML, Spotts B, et al. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy. J Urol 2000;164:322-5.
8. Sandhu SS, Symes A, A'Hern R, et al. Surgical excision of isolated renal-bed recurrence after radical nephrectomy for renal cell carcinoma. BJU Int 2005;95:522-5.
9. Levy DA, Swanson DA, Slaton JW, et al. Timely delivery of biological therapy after cytoreductive nephrectomy in carefully selected patients with metastatic renal cell carcinoma. J Urol 1998;159:1168-73.
10. Lam JS, Shvarts O, Leppert JT, et al. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy. J Urol 2005;173:1853-62.
11. Janzen NK, Kim HL, Figlin RA, et al. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am 2003;30:843-52.
12. Ljungberg B, Hanbury DC, Kuczyk MA, et al. Renal cell carcinoma guideline. Eur Urol 2007;51:1502-10.
13. Kim HL, Belldegrun AS, Freitas DG, et al. Paraneoplastic signs and symptoms of renal cell carcinoma: implications for prognosis. J Urol 2003;170:1742-6.
14. Kim HL, Han KR, Zisman A, et al. Cachexia-like symptoms predict a worse prognosis in localized t1 renal cell carcinoma. J Urol 2004;171:1810-3.
15. Patard JJ, Leray E, Cindolo L, et al. Multi-institutional validation of a symptom based classification for renal cell carcinoma. J Urol 2004;172:858-62.
16. Bensalah K, Leray E, Fergelot P, et al. Prognostic value of thrombocytosis in renal cell carcinoma. J Urol 2006;175:859-63. (Pubitemid 43199997)
17. Patard JJ, Kim HL, Lam JS, et al. Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study. J Clin Oncol 2004;22:3316-22.
18. Stephenson AJ, Chetner MP, Rourke K, et al. Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomy. J Urol 2004; 172:58-62.
19. Montie JE. Follow-up after partial or total nephrectomy for renal cell carcinoma. Urol Clin North Am 1994;21:589-92.
20. Sandock DS, Seftel AD, Resnick MI. A new protocol for the followup of renal cell carcinoma based on pathological stage. J Urol 1995;154:28-31.
21. Hafez KS, Novick AC, Campbell SC. Patterns of tumor recurrence and guidelines for followup after nephron sparing surgery for sporadic renal cell carcinoma. J Urol 1997; 157:2067-70.
22. Canfield SE, Kamat AM, Sánchez-Oritz RF, et al. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome. J Urol 2006;175:864-9.
23. Saidi JA, Newhouse JH, Sawczuk IS. Radiologic follow-up of patients with T1-3a,b,c or T4N+M0 renal cell carcinoma after radical nephrectomy. Urology 1998;52: 1000-3.
24. Han KR, Pantuck AJ, Bui MH, et al. Number of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma. Urology 2003;61:314-9.